Abzena

San Diego, CA; Bristol, PA; Cambridge, UK
Claimed Profile ADC AOC RDC PDC DAC Fusion Proteins Bispecifics bsAbs Multispecifics msAbs Bioconjugates Biologics mAb Monoclonal Antibody Antibodies Cytokines HPAPI Bioconjugation
Program data pending ClinicalTrials.gov matching · Last scored 2026-07-21
64.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Abzena

Signal Score
64.0/100 (as of 2026-07-21)
Quality Compliance
Assessment pending
Headquarters
San Diego, CA; Bristol, PA; Cambridge, UK
Founded
2001
Max Bioreactor Scale
2000L
Website
Modalities
ADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Abzena

Fully integrated discovery through commercial-scale CRO + CDMO for complex biologics and bioconjugates located in the US & UK. With over 25 years of experience de-risking and streamlining the design, development, and manufacture of mAbs, bispecifics, ADCs, AOCs, & RDCs to reach patients faster and with greater success.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 68.0
3 manufacturing sites
Broad modality coverage (18 modalities)
Sites: San Diego, CA, Bristol, PA, Cambridge, UK
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
StatusAvailable
3 manufacturing sites
Broad modality coverage (18 modalities)
Sites: San Diego, CA, Bristol, PA, Cambridge, UK
3 manufacturing sites
Broad modality coverage (18 modalities)

Frequently Asked Questions About Abzena

What is Abzena's CDMO Signal Score?
Abzena has a Signal Score of 64/100, based on quality, operations, financial stability, and capacity data.
Evaluating Abzena for a manufacturing program?
Use the free AI matchmaker to compare Abzena against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
ADC CDMOs → Bioconjugates CDMOs → Biologics CDMOs → HPAPI CDMOs → Bioconjugation CDMOs →

Similar CDMOs

Altruist Biologics
Suzhou, China
Biologics, mAb, Bispecific/Multispecific Antibodies, Fusion Proteins, Recombinant Proteins, ADC, Cell Therapy, Gene Therapy
Cerbios-Pharma
Lugano, Switzerland
ADC, HPAPI, Bioconjugation, Biologics, Oligonucleotides
Olon
Rodano (Milan), Italy
ADC (end-to-end), HPAPI, API (small molecule), Biologics (mammalian & microbial), mAb, Bioconjugation, Fill & Finish
LFB Biomanufacturing
Alès, France
Monoclonal Antibody, Recombinant Protein, Bispecifics, Fc-fusions, Biologics
Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma)
Lianyungang, China
Small Molecule API, Biologics, Monoclonal Antibody, ADC, Oncology Drugs, Surgical Medicines